MX2007002291A - Composicion antimicrobiana administrable oralmente. - Google Patents

Composicion antimicrobiana administrable oralmente.

Info

Publication number
MX2007002291A
MX2007002291A MX2007002291A MX2007002291A MX2007002291A MX 2007002291 A MX2007002291 A MX 2007002291A MX 2007002291 A MX2007002291 A MX 2007002291A MX 2007002291 A MX2007002291 A MX 2007002291A MX 2007002291 A MX2007002291 A MX 2007002291A
Authority
MX
Mexico
Prior art keywords
antimicrobial composition
composition
lactulose
perorally administrable
antibiotic
Prior art date
Application number
MX2007002291A
Other languages
English (en)
Inventor
Dmitry Sergeevich Chicherin
Original Assignee
Kiselev Nikolai Alexandovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36000449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007002291(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kiselev Nikolai Alexandovich filed Critical Kiselev Nikolai Alexandovich
Publication of MX2007002291A publication Critical patent/MX2007002291A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion se refiere a medicina y a la industria quimica y farmaceutica, en particular a formas de preparacion de antibioticos. La composicion antimicrobiana de la invencion contiene antibioticos seleccionados del grupo de: lincosamidas, penicilinas de amplio espectro, cefalosporinas, macrolidas, tetraciclinas, y lactulosa, como componentes activos, en una proporcion de 1:1 a 1:100. El tamano medio de particula de la lactulosa varia de 100 nm a 200 mum.
MX2007002291A 2004-08-30 2005-08-25 Composicion antimicrobiana administrable oralmente. MX2007002291A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2004126203/15A RU2284832C2 (ru) 2004-08-30 2004-08-30 Антимикробная композиция для перорального введения
PCT/RU2005/000434 WO2006025767A2 (fr) 2004-08-30 2005-08-25 Composition antimicrobienne destinee a une administration perorale

Publications (1)

Publication Number Publication Date
MX2007002291A true MX2007002291A (es) 2008-02-12

Family

ID=36000449

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002291A MX2007002291A (es) 2004-08-30 2005-08-25 Composicion antimicrobiana administrable oralmente.

Country Status (21)

Country Link
US (1) US8231871B2 (es)
EP (1) EP1790357B1 (es)
JP (1) JP5062480B2 (es)
CN (1) CN101031321B (es)
AT (1) ATE410185T1 (es)
AU (1) AU2005280704B2 (es)
BR (1) BRPI0514708A (es)
CA (1) CA2620919C (es)
DE (1) DE602005010280D1 (es)
DK (1) DK1790357T3 (es)
EA (1) EA200700357A1 (es)
ES (1) ES2314708T3 (es)
MX (1) MX2007002291A (es)
NZ (1) NZ554212A (es)
PL (1) PL1790357T3 (es)
PT (1) PT1790357E (es)
RU (1) RU2284832C2 (es)
TR (1) TR200703565T1 (es)
UA (1) UA85608C2 (es)
WO (1) WO2006025767A2 (es)
ZA (1) ZA200704449B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ544826A (en) 2003-07-25 2008-07-31 Warner Chilcott Co Inc A doxycycline metal complex in a solid dosage form
SG158869A1 (en) * 2005-01-21 2010-02-26 Warner Chilcott Co Llc A tetracycline metal complex in a solid dosage form
HUE028690T2 (en) 2008-03-18 2016-12-28 Dikovskiy Aleksander Vladimirovich Antibiotic and prebiotic pharmaceutical composition for antibacterial therapy to prevent and treat dysbiosis
CN101998859B (zh) * 2008-03-18 2014-03-05 亚历山大·弗拉基米罗维奇·季科夫斯基 用于预防与抗生素肠道给药相关的生态失调的药物组合物
JP6472788B2 (ja) 2013-05-07 2019-02-20 マイクロニクス， インコーポレイテッド 粘土鉱物およびアルカリ性溶液を使用して核酸含有試料を調製するための方法
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582068A (en) * 1977-12-09 1980-12-31 Morinaga Milk Industry Co Ltd Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder
IL75800A (en) * 1984-07-23 1988-11-30 Lilly Co Eli Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
JPH0614862B2 (ja) * 1987-05-22 1994-03-02 東京田辺製薬株式会社 ビフィドバクテリウム菌の増殖促進剤
JPS6483025A (en) * 1987-09-24 1989-03-28 Fujio Hayashi Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
IE68841B1 (en) * 1988-03-18 1996-07-10 Duphar Int Res Method of preparing solid lactulose
FI87880C (fi) * 1990-06-27 1993-03-10 Valio Meijerien Foder som befraemjar tillvaexten och tarmfunktionen hos djur
AU689250B2 (en) * 1994-04-22 1998-03-26 Astellas Pharma Inc. Colon-specific drug release system
JP2000516222A (ja) * 1996-08-15 2000-12-05 ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング 嚥下が容易な経口医薬組成物
JPH10194975A (ja) * 1997-01-10 1998-07-28 Morinaga Milk Ind Co Ltd 肝疾患治療剤
IT1297538B1 (it) * 1997-08-01 1999-12-17 Francesco Vicidomini Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
FR2769839B1 (fr) * 1997-10-21 1999-12-17 Odette Mercedes Salsarulo Composition anhydre a base de lactulose
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
RU2131260C1 (ru) * 1998-10-14 1999-06-10 Плисов Николай Валерьевич Препарат для лечения желудочно-кишечных заболеваний
AU772633B2 (en) * 1999-03-03 2004-05-06 Eli Lilly And Company Echinocandin/carbohydrate complexes
EP1184038B1 (en) * 1999-06-09 2005-12-28 Mochida Pharmaceutical Co., Ltd. System for release in lower digestive tract

Also Published As

Publication number Publication date
EP1790357A4 (en) 2007-11-07
DK1790357T3 (da) 2009-02-02
WO2006025767A2 (fr) 2006-03-09
JP2008511622A (ja) 2008-04-17
BRPI0514708A (pt) 2008-06-24
CN101031321A (zh) 2007-09-05
NZ554212A (en) 2009-08-28
EP1790357A2 (en) 2007-05-30
ZA200704449B (en) 2008-08-27
EP1790357B1 (en) 2008-10-08
DE602005010280D1 (de) 2008-11-20
WO2006025767A3 (fr) 2006-08-17
US8231871B2 (en) 2012-07-31
ES2314708T3 (es) 2009-03-16
CA2620919C (en) 2014-10-14
EA010199B1 (ru) 2008-06-30
TR200703565T1 (tr) 2007-08-21
RU2004126203A (ru) 2006-02-10
WO2006025767A8 (fr) 2007-04-05
EA200700357A1 (ru) 2008-06-30
PT1790357E (pt) 2008-12-31
CN101031321B (zh) 2010-12-15
CA2620919A1 (en) 2006-03-09
ATE410185T1 (de) 2008-10-15
AU2005280704B2 (en) 2010-10-07
JP5062480B2 (ja) 2012-10-31
UA85608C2 (ru) 2009-02-10
RU2284832C2 (ru) 2006-10-10
AU2005280704A1 (en) 2006-03-09
US20070254023A1 (en) 2007-11-01
PL1790357T3 (pl) 2009-03-31

Similar Documents

Publication Publication Date Title
MX2007002291A (es) Composicion antimicrobiana administrable oralmente.
JP2005524658A5 (es)
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
WO2006035418A3 (en) Microcapsules comprising a methylxanthine and a corticosteroid
CA2115381A1 (en) Rifaximin and Pharmaceutical Compositions Containing It in the Treatment of Gastric Dyspepsia Caused by Helicobacter Pylori
WO2008027993A3 (en) Drug delivery systems comprising solid solutions of weakly basic drugs
BR0008059A (pt) Composições de valdecoxib
HK1140947A1 (en) Pharmaceuticals compositions of a neuroactive steroid and uses thereof
WO2005117895A3 (en) Compositions comprising meloxicam
WO2009121063A3 (en) Chemokine receptor modulators
WO2004087043A3 (en) Stable ophthalmic formulation containing an antibiotic and a corticosteroid
WO2008017867A3 (en) Antiretroviral solid oral composition with at least one water insoluble polymer
WO2003028696A3 (en) Compositions for delivery of drug combinations
WO2006021160A8 (en) Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application
WO2007075794A3 (en) Oral formulations comprising tigecycline
WO2005041934A3 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
WO2008013630A3 (en) Calcium aluminosilicate pharmaceutical
WO2008006534A3 (en) Multiple unit tablets
BR0111868A (pt) Composições farmacêuticas
MX2009003360A (es) Formulaciones orales liofilizadas de desintegracion rapida de un antagonista del receptor de trombina.
WO2007011958A3 (en) Intraoral dosage forms of glucagon
WO2005009407A3 (en) Oral pharmaceutical formulations of olanzapine
BG103958A (en) Pharmaceutical compositions of thioxanide and nitazoxanide
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins
WO2003075852A3 (en) Antibiotic composition

Legal Events

Date Code Title Description
FG Grant or registration